Listed on
(Coverage)
JCR2006-2023
SJR2005-2020;2022-2023
CiteScore2011-2023
SCIE2010-2024
SCOPUS2017-2024
DOAJ2021-2024
EMBASE2016-2024
OA Info.
| OA |
oa mark
based on the information
- 2021;2022;2023;2024;2025;
|
| Keywords |
engineering of biomolecules, engineering metabolic pathways, bioproduct engineering, biosynthesis, biotransformation, bioreactors |
| Review Process |
Anonymous peer review |
Journal info.
pages |
|
| Licences |
CC BY, CC BY-NC, CC BY-NC-ND |
| Copyrights |
No |
| DOAJ Coverage |
Added on Date : 2020-11-17T15:15:53Z |
| Subject(s) |
Technology: Chemical technology: Biotechnology |
Country
USA
Aime & Scopes
Engineering in Life Sciences (ELS) focuses on engineering principles and innovations in life sciences and biotechnology. Life sciences and biotechnology covered in ELS encompass the use of biomolecules (e.g. proteins/enzymes) and cells (microbial, plant and mammalian origins) for biosynthesis, biotransformation, cell-based treatment and bio-based solutions in industrial and pharmaceutical biotechnologies as well as in biomedicine. ELS especially aims to promote interdisciplinary collaborations among biologists, biotechnologists and engineers for quantitative understanding and holistic engineering (design-built-test) of biological parts and processes in the different application areas. Applying this engineering mindset, ELS addresses scientific questions and technologies, for example, regarding:
/// Engineering electron transfer for biosynthesis and biotransformation (e.g. via photo- and electrobiotechnology)
/// Developing quantitative tools for engineering of biomolecules (e.g. DNA/genome, RNA and proteins) and bioproduction chassis
/// Accessing novel biomolecules and biomaterials (e.g. proteins, natural and aroma compounds, fine chemicals and building blocks)
/// Engineering metabolic pathways and their regulation (e.g. in the context of metabolic engineering and synthetic biology)
/// Unravelling cellular regulation and cell-to-cell interactions (e.g. microbiome, co-cultures, stem cells and tissues)
/// Engineering novel bioreactors and bioprocesses (e.g. for the production of biopharmaceuticals, fine chemicals, commodities and biofuels, including use of waste streams and alternative feedstock)
